Verapamil therapy for stable and unstable angina pectoris: calcium channel antagonists in perspective.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000787:Angina Pectoris / Q000188:drug therapy* / Q000503:physiopathology; D000788:Angina Pectoris, Variant / Q000188:drug therapy; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D003864:Depression, Chemical; D004347:Drug Interactions; D006801:Humans; D009200:Myocardial Contraction / Q000187:drug effects; D009543:Nifedipine / Q000627:therapeutic use; D010919:Placebos; D011433:Propranolol / Q000627:therapeutic use; D014700:Verapamil / Q000494:pharmacology / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D010919:Placebos; D011433:Propranolol; D014700:Verapamil; D009543:Nifedipine